Research changes the world.
TEMPOS is a user-friendly rating scale that can be used to assess adherence to reporting recommendations.
Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
Dr. Apiou’s focus is on teaching and practicing unique models of innovation through collaboration across academia and industry.
A unique collaborative effort seeks to reduce the environmental impact of biomedical research.
Dr. Ruiz is studying the interactions of the immune system with tumor cells in the brain and neck. He also loves dancing and bike riding.
Despite being a treatable disease, osteoporosis remains underdiagnosed and undertreated, with Black women experiencing the most disparities.
The National Institutes of Health’s All of Us Research Program has reached an important milestone with the release of its initial genomic dataset.
While you may think that personal care products undergo the same regulatory scrutiny as food or medicine, there are few safeguards in place.
A study of individuals experiencing homelessness in Boston shows a worrying increase in the number of deaths due to synthetic opioids and the use of multiple substances.
Sending handwritten cards to the families of patients who died in the ICU during the COVID-19 pandemic has been a way to remember their individual stories.